ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BCRX announcements Biocryst Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Biocryst Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Biocryst Pharmaceuticals, Inc. BCRX

Biocryst Pharmaceuticals, Inc. BCRX listed on NASDAQ and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Biocryst Pharmaceuticals, Inc. BCRX

BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates
BioCryst (BCRX) delivered earnings and revenue surprises of +400.00% and +9.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Announcement as on 04 August 2025

BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates
BioCryst (BCRX) delivered earnings and revenue surprises of +400.00% and +9.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Announcement as on 04 August 2025

BioCryst Pharmaceuticals' ORLADEYO® Approved for National Reimbursement in the Netherlands for HAE Prevention
BioCryst Pharmaceuticals announces ORLADEYO® approval for HAE prevention in the Netherlands, expanding European access to the first oral therapy.
Announcement as on 06 June 2025

BioCryst Pharmaceuticals to Present New Data on ORLADEYO® for Hereditary Angioedema at EAACI 2025 Meeting
BioCryst Pharmaceuticals will present new data on ORLADEYO for hereditary angioedema at the EAACI meeting in Glasgow.
Announcement as on 02 June 2025

BioCryst Pharmaceuticals (BCRX) Reports Q4 Loss, Tops Revenue Estimates
BioCryst (BCRX) delivered earnings and revenue surprises of -116.67% and 0.56%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Announcement as on 24 February 2025

Announcements by Biocryst Pharmaceuticals, Inc. first page | Next page |

BCRX Biocryst Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Biocryst Pharmaceuticals, Inc.

  • 5Day Average: 7.51
  • 12Day Average: 7.21
  • 20Day Average: 7.16
  • 50Day Average: 7.14
  • 100Day Average: 7.69
  • 150Day Average: 8.46
  • 200Day Average: 8.27

BCRX Indicators & signals

Indicator MACD (12,26,9)

7.34, 7.23, 0.01
Indicator MACD is in positive zone

Indicator ADX (14)

10, 34.38, 28.13
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BCRX Biocryst Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 7.59 7.45 to 7.93 -3.19% 0.77 times
04 Thu Dec 2025 7.84 7.79 to 8.17 -0.13% 1.28 times
03 Wed Dec 2025 7.85 7.11 to 7.88 9.64% 1.83 times
02 Tue Dec 2025 7.16 7.11 to 7.30 0.42% 0.86 times
01 Mon Dec 2025 7.13 7.02 to 7.20 -0.7% 0.77 times
28 Fri Nov 2025 7.18 7.05 to 7.23 0.84% 0.36 times
26 Wed Nov 2025 7.12 6.81 to 7.14 3.94% 0.67 times
25 Tue Nov 2025 6.85 6.71 to 7.01 0.29% 1.26 times
24 Mon Nov 2025 6.83 6.71 to 7.05 -2.01% 1.19 times
21 Fri Nov 2025 6.97 6.95 to 7.17 -0.85% 0.94 times
20 Thu Nov 2025 7.03 6.89 to 7.09 1.44% 0.86 times
19 Wed Nov 2025 6.93 6.73 to 7.07 -0.86% 0.78 times

Videos related to: BCRX announcements Biocryst Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

BCRX announcements Biocryst Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

 

Back to top